ValiRx plc (AIM:VAL)
London
· Delayed Price · Currency is GBP · Price in GBX 0.6000
-0.0400 (-6.67%)
Jul 3, 2025, 4:35 PM GMT+1
ValiRx Market Cap
ValiRx has a market cap or net worth of 2.25 million as of July 3, 2025. Its market cap has decreased by -34.73% in one year.
Market Cap
2.25M
Enterprise Value
300.28K
Revenue
49.78K
Ranking
n/a
PE Ratio
n/a
Stock Price
0.60
Market Cap Chart
Since October 3, 2006, ValiRx's market cap has decreased from 12.83M to 2.25M, a decrease of -82.50%. That is a compound annual growth rate of -8.87%.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| AstraZeneca | 161.30B |
| GSK plc | 57.16B |
| Haleon | 33.75B |
| Smith & Nephew | 9.79B |
| ConvaTec Group | 5.56B |
| Hikma Pharmaceuticals | 4.39B |
| HUTCHMED (China) | 1.91B |
| Oxford Nanopore Technologies | 1.34B |